Internet

AHNLAB,INC. Reports First-Half Operating Profit of 7.3 Billion Won... Up 62.3% Year-Over-Year

Revenue rose 9.1% year-over-year to 10.9 billion won

Kang Min-koo
2026-07-29 11:15:53
[Edaily Reporter Kang Min-koo ] AHNLAB,INC.(053800)announced preliminary financial results on the 29th, reporting consolidated revenue of 130.4 billion won and operating profit of 7.3 billion won for the first half of this year.

(Source: AHNLAB,INC.)

Revenue increased by 10.9 billion won (9.1%) year-over-year, while operating profit rose by 2.8 billion won (62.3%).

In the second quarter of this year, consolidated revenue was 71.3 billion won, and operating profit was 5.4 billion won. Compared to the same period last year, revenue rose by 9.0 billion won (14.5%), and operating profit increased by 1.9 billion won (55.6%).

AHNLAB,INC. official stated, “Revenue from our global business, centered on our Saudi Arabian joint venture ‘Rakin,’ grew by more than double digits compared to the same period last year,” adding, “Amid growing adoption of N²SF and Zero Trust-related products such as AHNLAB EDR and XTG, we recorded triple-digit revenue growth year-over-year.”

The spokesperson added, “We will continue to strengthen the competitiveness of our AI-based products and services,” and noted, “We will also expand our global business to maintain this robust growth momentum.”

Consolidated financial results for the first half of the year. (Unit: million won) (Source: AHNLAB,INC.)

Economy

Corporation

IT·Science

Economy

Money Flows into AI Side Effects… Investment in Verified Startups Booms in Europe

As the spread of fraud and misinformation using artificial intelligence (AI) continues to rise, investment is flowing into European startups that verify AI-generated content. The scope of investment i…
2026-11-20 18:25:06

Corporation

Curocell Inc.’s “Limcato” to Be Covered by National Health Insurance Starting in December… Price Per Dose: 280 Million Won

“Limcato,” developed by Curocell Inc. and Korea’s first domestically produced chimeric antigen receptor T-cell (CAR-T) therapy, is set to be covered by the National Health Insurance. This is expected …
2026-11-20 17:18:01

IT·Science

CJ ENM CO., Ltd. Files for Preliminary Injunction to Halt LG HelloVision Channel Broadcasts… “We Will Protect Viewers’ Right to Choose”

CJ ENM CO., Ltd.(035760)has filed a petition for a preliminary injunction with the court, asking it to prevent LG HelloVision(037560)from suspending broadcasts on its four channels. (Photo: CJ ENM …
2026-11-20 17:17:14